David John Kuter, M.D., Dr.Phil.
Co-Author
This page shows the publications co-authored by David Kuter and Hanny Al-Samkari.
Connection Strength
14.274
-
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021 04 01; 106(4):1148-1157.
Score: 0.929
-
The role of romiplostim for pediatric patients with immune thrombocytopenia. Ther Adv Hematol. 2020; 11:2040620720912992.
Score: 0.871
-
A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 2020 01 14; 4(1):9-18.
Score: 0.854
-
Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment. Semin Thromb Hemost. 2020 Apr; 46(3):275-288.
Score: 0.849
-
Lactate dehydrogenase is elevated in immune thrombocytopenia and inversely correlates with platelet count. Br J Haematol. 2019 11; 187(3):e61-e64.
Score: 0.833
-
Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia. Ther Adv Hematol. 2019; 10:2040620719841735.
Score: 0.810
-
Recurrence of Acute Intermittent Porphyria After Liver Transplantation. Ann Intern Med. 2019 06 18; 170(12):904-905.
Score: 0.800
-
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Ann Hematol. 2019 Mar; 98(3):581-588.
Score: 0.788
-
Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. J Intern Med. 2019 02; 285(2):223-231.
Score: 0.782
-
Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations. Haematologica. 2018 10; 103(10):e492-e495.
Score: 0.781
-
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol. 2018 12; 93(12):1501-1508.
Score: 0.780
-
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia. Br J Clin Pharmacol. 2018 11; 84(11):2673-2677.
Score: 0.774
-
Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. Br J Haematol. 2018 10; 183(2):168.
Score: 0.768
-
Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 07; 182(1):106-113.
Score: 0.761
-
The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018 04; 103(4):e169-e172.
Score: 0.739
-
Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. Am J Hematol. 2021 12 01; 96(12):1563-1568.
Score: 0.239
-
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2021 08 01; 106(8):2161-2169.
Score: 0.238
-
An evaluation of avatrombopag for the treatment of thrombocytopenia. Expert Opin Pharmacother. 2021 Feb; 22(3):273-280.
Score: 0.226
-
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19). Am J Hematol. 2020 12; 95(12):1479-1485.
Score: 0.223
-
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 07 23; 136(4):489-500.
Score: 0.221
-
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. Am J Hematol. 2020 Jul 03.
Score: 0.221
-
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features. Res Pract Thromb Haemost. 2020 Jul; 4(5):807-812.
Score: 0.220
-
Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance. Blood Adv. 2019 11 26; 3(22):3515-3521.
Score: 0.212
-
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective. Haematologica. 2018 09; 103(9):1433-1443.
Score: 0.191
-
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood. 2022 03 10; 139(10):1564-1574.
Score: 0.062
-
Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia. Clin Transl Gastroenterol. 2020 01; 11(1):e00118.
Score: 0.053
-
Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth. 2019 Jan; 122(1):19-31.
Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.